Caplin Point Laboratories Ltd. — Investor Relations & Filings
Caplin Point Laboratories Ltd. is a pharmaceutical organization focused on the development, manufacturing, and marketing of finished dosage forms. Its extensive product portfolio encompasses tablets, capsules, injections, liquid orals, and softgel capsules across diverse therapeutic categories. The company utilizes a vertically integrated business model, overseeing the complete value chain from research and development to final distribution. Caplin Point maintains a significant market presence in Latin America and Francophone Africa, supported by a specialized end-to-end logistics and supply chain network. Furthermore, through its subsidiary Caplin Steriles, the company has established a footprint in regulated markets, specializing in sterile injectables and ophthalmic products. Its manufacturing infrastructure is designed to meet global regulatory requirements, including certifications from the US FDA and EU GMP.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-07 | English | |
| Press Release | 2026-05-05 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-06 | English | |
| Trading Window | 2026-03-27 | English | |
| Press Release | 2026-03-13 | English | |
| Cessation | 2026-03-03 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42853900 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-07 | English | ||
| 42193426 | Press Release | 2026-05-05 | English | ||
| 42209107 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-06 | English | ||
| 42213262 | Trading Window | 2026-03-27 | English | ||
| 42199015 | Press Release | 2026-03-13 | English | ||
| 42175465 | Cessation | 2026-03-03 | English | ||
| 42190574 | Press Release | 2026-02-28 | English | ||
| 42185175 | Press Release | 2026-02-24 | English | ||
| 42197934 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-02-11 | English | ||
| 42162579 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-02-05 | English | ||
| 42180729 | Investor Presentation | 2026-02-05 | English | ||
| 42183832 | Outcome of Board Meeting | 2026-02-05 | English | ||
| 42220110 | Change in Director(s) | 2026-02-03 | English | ||
| 42220381 | Shareholders meeting | 2026-02-03 | English | ||
| 42173993 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-01-29 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
China Medical System Holdings Limited
Innovation-driven specialty pharmaceutical group engaged in…
|
867 | KY | Manufacturing |
|
China NT Pharma Group Company Limited
Engaged in biotech R&D, manufacturing, sales, and marketing…
|
1011 | HK | Manufacturing |
|
CHINA PHARMA HOLDINGS, INC.
Develops, manufactures, and markets prescription, OTC, and …
|
CPHI | US | Manufacturing |
|
China Regenerative Medicine International Limited
Develops, produces, and sells tissue engineering and regene…
|
8158 | HK | Manufacturing |
|
China Resources Boya Bio-pharmaceutical Group Co., Ltd
Researches and produces blood products and plasma-derived m…
|
300294 | CN | Manufacturing |
|
China Resources Double-Crane Pharmaceutical Co.,Ltd.
Develops and manufactures chronic disease medications and p…
|
600062 | CN | Manufacturing |
|
CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO.,LTD
Develops and produces OTC medicines, TCM, and supplements f…
|
600750 | CN | Manufacturing |
|
China Resources Pharmaceutical Group Limited
Integrated pharmaceutical value chain encompassing R&D, man…
|
3320 | HK | Manufacturing |
|
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Develops and sells consumer healthcare and prescription dru…
|
000999 | CN | Manufacturing |
|
China Shineway Pharmaceutical Group Limited
R&D, manufacturing, and distribution of modern Chinese medi…
|
2877 | KY | Manufacturing |
Caplin Point Laboratories Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61439/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61439 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61439 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61439 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61439}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Caplin Point Laboratories Ltd. (id: 61439)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.